Back to top
more

VanEck Vectors Generic Drugs ETF: (GNRX)

(Delayed Data from NASDAQ) As of Oct 16, 2018 03:00 PM ET

 Add to portfolio

$24.24 USD

24.24
NA

0.00 (0.00%)

Volume: NA

Zacks ETF Rank NA

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 24.24
Open 24.10
Bid 23.47
Ask 24.72
Day Low-High 24.10-24.25
52wk Low-High 22.66-26.68
Volume NA
NAV (month end) NA

Zacks Premium Research for GNRX

Zacks ETF Rank NA
ETF Risk NA

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.57%
Dividend (Yield) $0.37 (1.51%)
Issuer VAN ECK

Benchmark for GNRX

INDXX GLOBAL GENERICS & NEW PHARMA INDEX

The Indxx Global Generics & New Pharma Index tracks the overall performance of companies that derive a significant proportion of their revenues or that have the potential to derive a significant proportion of their revenues from the generic drug industry, or that have a primary business focus on the generic drug industry.

Fund Summary for GNRX

VANECK VECTORS GENERIC DRUGS ETF

The VanEck Vectors Generic Drugs ETF replicates as closely as possible, before fees and expenses, the price and yield performance of Indxx Global Generics & New Pharma Index.